| 1 |
Amorolfine Cream 0.25%w/w |
|
| |
Composition: |
|
| |
Amorolfine HCl IP |
|
| |
Eq. to Amorolfine 0.25 % w/w |
|
| |
Phenoxyethanol IP 1.0% w/w |
|
| |
(As Presrvative) |
|
| |
Cream base q.s |
|
| 2 |
Beclomethasone Dipropionate, Clotrimazole & Neomycin Sulphate Cream |
|
| |
Composition: |
|
| |
Beclomethasone Dipropionate IP 0.025% w/w |
|
| |
Clotrimazole IP 1.0% w/w |
|
| |
Neomycin Sulphate IP 0.5 % w/w |
|
| |
In a cream base |
|
| 3 |
Bifonazole Cream IP 1.0 % w/w |
|
| |
Composition: |
|
| |
Bifonazole IP 1.0% w/w |
|
| |
Cream base q.s. |
|
| 4 |
Ciprofloxacin, Metronidazole, Terbinafine & Clobetasol Propionate Cream |
|
| |
Composition: |
|
| |
Ciprofloxacin HCl IP 1.0% w/w |
|
| |
Metronidazole Benzoate IP 1.0% w/w |
|
| |
Terbinafine HCl IP 1.0% w/w |
|
| |
Clobetasol Propionate IP 0.5% w/w |
|
| |
Cream base q.s. |
|
| 5 |
Clobetasol Propionate & Salicylic Acid Cream |
|
| |
Composition: |
|
| |
Clobetasol Propionate USP….. 0.05% w/w |
|
| |
Salicylic Acid IP……………. 3.0 % w/w |
|
| |
Cream base……. q.s. |
|
| 8 |
Clobetasol Propionate, Ofloxacin, Ornidazole, Itraconazole, Methyl Paraben, Propyl Paraben Cream |
|
| |
Composition: |
|
| |
Clobetasol Propionate IP 0.05% w/w |
|
| |
Ofloxacin IP 0.75% w/w |
|
| |
Ornidazole IP 2.0% w/w |
|
| |
Itraconazole IP 1.0% w/w |
|
| |
Methyl Paraben IP 0.2% w/w |
|
| |
Propyl Paraben IP 0.2% w/w |
|
| |
Cream base q.s. |
|
| 9 |
Clobetasol Propionate, Miconazole Nitrate & Neomycin Sulphate Cream |
|
| |
Composition |
|
| |
Clobetasol Propionate IP 0.05%w/w, |
|
| |
Miconazole Nitrate IP 2.0% w/w, |
|
| |
Neomycin Sulphate IP 0.5%w/w |
|
| |
Cream Base q.s. |
|
| 11 |
Clotrimazole, BeclomethasoneDipropionate & Gentamicin Cream |
|
| |
Composition: |
|
| |
Clotrimazole IP 1.0 %w/w |
|
| |
Beclomethasone Dipropionate IP 0.025%w/w |
|
| |
Gentamicin Cream IP 0.1%w/w |
|
| |
Cream Base q.s. |
|
| 12 |
Crotamiton & Hydrocortisone Cream |
|
| |
Composition: |
|
| |
Crotamiton IP 10.0% w/w |
|
| |
Hydrocortisone IP 0.25% w/w |
|
| |
Cream base q.s. |
|
| 13 |
Desonide Cream 0.05% w/w |
|
| |
Composition: |
|
| |
Desonide 0.05% w/w |
|
| |
Cream base q.s. |
|
| 14 |
Eberconazole Cream 1% w/w |
|
| |
Composition: |
|
| |
Eberconazole Nitrate IP |
|
| |
Eq. to Eberconazole 1.0% w/w |
|
| |
Cream base q.s. |
|
| |
Preservatives |
|
| |
Methylparaben IP 0.1% w/w |
|
| |
Propylparaben IP 0.025% w/w |
|
| 16 |
Fusidic Acid & Beclomethasone Valerate cream |
|
| |
Composition: |
|
| |
Fusidic Acid IP 2% w/w |
|
| |
Beclomethasone valerate IP 0.10% w/w |
|
| |
Chlorocresol IP 0.12% w/w |
|
| |
(As preservative) |
|
| |
Cream Base q.s. |
|
| 17 |
Fusidic Acid & Beclomethasone Dipropionate Cream |
|
| |
Composition: |
|
| |
Each gram contains: |
|
| |
Fusidic Acid IP 20mg |
|
| |
Beclomethasone Dipropionate IP 0.25mg |
|
| |
In a water miscible cream base |
|
| 18 |
Fusidic Acid Cream IP 2%w/w |
|
| |
Composition: |
|
| |
Fusidic Acid IP 2.0%w/w |
|
| |
Cream base q.s. |
|
| 19 |
Halobetasol Propionate & Miconazole Nitrate Cream |
|
| |
Composition: |
|
| |
Halobetasole Propionate USP 0.5% w/w |
|
| |
Miconzaole Nitrate IP 2.0% w/w |
|
| |
Cream base q.s. |
|
| 20 |
Hydroquinone, Tretinoin & Allantoin Cream |
|
| |
Composition: |
|
| |
Hydroquinone USP 2.0%w/w |
|
| |
Tretinoin USP 0.025%w/w |
|
| |
Allantoin IP 1.0%w/w |
|
| |
Cream base q.s. |
|
| 21 |
Hydroquinone, Tretinoin & Mometasone Furoate Cream |
|
| |
Composition: |
|
| |
Hydroquinone USP 2.0%w/w |
|
| |
Tretinoin USP 0.025%w/w |
|
| |
Mometasone Furoate IP 0.1%w/w |
|
| |
Cream base q.s. |
|
| 22 |
Ivermectin Cream 1% w/w |
|
| |
Composition |
|
| |
Ivermectin IP 1% w/w |
|
| |
Cream base q.s. |
|
| 23 |
Ketoconazole Cream 2.0%w/w |
|
| |
Composition |
|
| |
Ketoconazole IP 2.0% w/w |
|
| |
Cream base q.s. |
|
| 24 |
Kojic Acid and Vitamin C Cream |
|
| |
Composition |
|
| |
Kojic Acid 0.75% w/w |
|
| |
Vitamin C IP 2.5% w/w |
|
| |
Cream base q.s. |
|
| 25 |
Lidocaine and Prilocaine Cream IP |
|
| |
Composition: |
|
| |
Each gram contains: |
|
| |
Lidocaine IP 25mg |
|
| |
Prilocaine IP 25mg |
|
| |
In water miscible base |
|
| 26 |
Luliconazole Cream IP 1% w/w |
|
| |
Composition: |
|
| |
Luliconazole IP 1.0% w/w |
|
| |
Cream base q.s. |
|
| 27 |
Luliconazole & Beclomethasone Dipropionate Cream |
|
| |
Composition: |
|
| |
Luliconazole IP 1.0% w/w |
|
| |
Beclomethasone Dipropionate IP 0.025% w/w |
|
| |
Cream base q.s. |
|
| 28 |
Luliconazole & Clobetasol Propionate Cream |
|
| |
Composition: |
|
| |
Luliconazole IP 1.0% w/w |
|
| |
Clobetasol Propionate IP 0.05%w/w |
|
| |
Cream base q.s. |
|
| 29 |
Liquid Paraffin & White Soft Paraffin Cream |
|
| |
Composition: |
|
| |
Liquid Paraffin IP 10.2% w/w |
|
| |
White Soft Paraffin IP 13.2% w/w |
|
| |
Cream base q.s. |
|
| 30 |
Mometasone Furoate 0.1% & Fusidic Acid 2% Cream |
|
| |
Composition: |
|
| |
Mometasone Furoate IP 0.1% w/w |
|
| |
Fusidic Acid IP 2.0% w/w |
|
| |
Cream base q.s. |
|
| 31 |
Mometasone Furoate & Nadifloxacin Cream |
|
| |
Composition: |
|
| |
Mometasone Furoate IP 0.1% w/w |
|
| |
Nadifloxacin IP 1.0% w/w |
|
| |
Cream base q.s |
|
| 32 |
Mometasone Furoate & Terbinafine Hydrochloride Cream |
|
| |
Composition: |
|
| |
Mometasone Furoate IP 0.1% w/w |
|
| |
Terbinafine Hydrochloride IP 1.0% w/w |
|
| |
Cream base q.s |
|
| 33 |
Mometasone Furoate Cream IP 0.1% w/w |
|
| |
Composition: |
|
| |
Mometasone Furoate IP 0.1% w/w |
|
| |
Cream base q.s |
|
| 34 |
Permethrin Cream 5% w/w |
|
| |
Composition |
|
| |
Permethrin 5.0% w/w |
|
| |
Cream base q.s. |
|
| 35 |
Sertaconazole Nitrate Cream 2% w/w |
|
| |
Composition: |
|
| |
Sertaconazole Nitrate IP 2.0% w/w |
|
| |
Cream base q.s. |
|
| |
Preservative |
|
| |
Benzyl Alcohol IP 1.0 w/w |
|
| 36 |
Silver Sulphadiazine & Chlorhexidine Gluconate Cream |
|
| |
Composition: |
|
| |
Silver Sulphadiazine USP 1.0 % w/w |
|
| |
Chlorhexidine Gluconate Solution BP |
|
| |
Chlorhexidine Gluconate 0.2 % w/w |
|
| |
Cream base q.s |
|
| 37 |
Tretinoin Cream USP 0.025% w/w |
|
| |
Composition: |
|
| |
Tretinoin USP 0.025% w/w |
|
| |
Cream base q.s. |
|
| 38 |
White Soft Paraffin 15% & Light Liquid Paraffin 6% Cream (Lotion Base) |
|
| |
Composition: |
|
| |
White Soft Paraffin IP 15.0% w/w |
|
| |
Liquid Paraffin IP 6.0% w/w |
|
| |
Lotion base q.s. |
|
| 39 |
White soft Paraffin, Liquid paraffin, Methylparaben & Propylparaben Cream |
|
| |
Composition |
|
| |
White soft Paraffin IP 7.0% w/w |
|
| |
Liquid paraffin IP 3.0% w/w |
|
| |
Methylparaben IP 0.18% w/w |
|
| |
Propylparaben IP 0.02% w/w |
|
| |
Cream base q.s. |
|
| 40 |
Ketoconazole, Clobetasol Propionate, Tolnaftate, Lodochlorhydroxyquinoline & Neomycin Sulphate Cream |
|
| |
Composition: |
|
| |
Ketoconazole IP 2.0% w/w |
|
| |
Clobetasole Propionate IP 0.05% w/w |
|
| |
Tolnaftate IP 1.0% w/w |
|
| |
Iodochlorhydroxyquinoline IP 1.0% w/w |
|
| |
Neomycin Sulphate IP 0.10% w/w |
|
| |
Cream base q.s. |
|
| 41 |
Aceclofenac, Linseed Oil, Menthol, Methyl Salicylate & Capsaicin Gel |
|
| |
Composition |
|
| |
Acelofenac IP 1.5%w/w |
|
| |
Linseed Oil BP 3%w/w |
|
| |
Menthol IP 5% w/w |
|
| |
Methyl Salicylate IP 10% w/w |
|
| |
Capsaicin USP 0.025% w/w |
|
| |
Gel base q.s. |
|
| 42 |
Beclomethasone Dipropionate & Salicylic Acid Ointment |
|
| |
Composition |
|
| |
Beclomethasone Dipropionate IP 0.025% w/w |
|
| |
Salicyclic Acid IP 3.0% w/w |
|
| |
In an Ointment base q.s. |
|
| 43 |
Benzoic Acid & Salicylic Acid Ointment |
|
| |
Composition: |
|
| |
Benzoic Acid IP 6.0% w/w |
|
| |
Salicylic Acid IP 3.0% w/w |
|
| |
In an Ointment base q.s. |
|
| 44 |
Clindamycin Phosphate 1% + Isotretinoin 0.05% Gel |
|
| |
Composition: |
|
| |
Clindamycin Phosphate IP |
|
| |
Eq. to Clindamycin 1.0% w/w |
|
| |
Isotretinoin IP 0.05% w/w |
|
| |
Gel base q.s. |
|
| 45 |
Clindamycin Phosphate & Benzoyl Peroxide Gel |
|
| |
Composition: |
|
| |
Clindamycin Phosphate IP |
|
| |
Eq. to Clindamycin 1.0% w/w |
|
| |
Hydrous Benzoyl Peroxide IP |
|
| |
Eq. to Anhydrous Benzoyl Peroxide 2.5% w/w |
|
| |
Gel base q.s. |
|
| 46 |
Clindamycin Phosphate & Nicotinamide Gel |
|
| |
Composition: |
|
| |
Clindamycin Phosphate IP |
|
| |
Eq. to Clindamycin 1.0% w/w |
|
| |
Nicotinamide IP 4.0% w/w |
|
| |
Gel base q.s. |
|
| 47 |
Clobetasol Propionate & Salicylic Acid Ointment |
|
| |
Composition: |
|
| |
Clobetasol Propionate IP 0.05%w/w |
|
| |
Salicylic Acid IP 3.0%w/w |
|
| |
Ointment base q.s. |
|
| 48 |
Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate, Capsaicin & Menthol Gel |
|
| |
Composition: |
|
| |
Diclofenac Diethylamine IP 1.16% w/w |
|
| |
Eq. to. Diclofenac Sodium IP 1.0 % w/w |
|
| |
Linseed Oil BP 3.0 % w/w |
|
| |
Methyl Salicylate IP 10.0% w/w |
|
| |
Capsaicin 0.01 % w/w |
|
| |
Menthol IP 5.0 % w/w |
|
| |
Benzyl Alcohol Gel IP 1.0 % w/w |
|
| |
(As Preservative) |
|
| |
In a Gel base q.s. |
|
| 49 |
Fusidic Acid Ointment 2%w/w |
|
| |
Composition: |
|
| |
Fusidic Acid IP 2.0%w/w |
|
| |
Ointment base q.s. |
|
| 50 |
Isotretinoin Gel 0.05% w/w |
|
| |
Composition: |
|
| |
Isotretinoin IP 0.05% w/w |
|
| |
Gel base q.s. |
|
| 51 |
Lignocaine Gel IP 2%w/v |
|
| |
Composition: |
|
| |
Lignocaine Hydrochloride IP |
|
| |
Eq. to Anhydrous |
|
| |
Lignocaine Hydrochloride 2.0%w/v |
|
| |
Preservatives |
|
| |
Methylparaben IP 0.061% w/v |
|
| |
Propylparaben IP 0.027% w/v |
|
| |
Gel base q.s. |
|
| 52 |
L-Lysine Hydrochloride Gel 15% w/w |
|
| |
Composition: |
|
| |
L-Lysine Hydrochloride USP 15% w/w |
|
| |
Preservatives |
|
| |
Sodium Methylparaben IP 0.2% w/w |
|
| |
Sodium Propylparaben IP 0.02% w/w |
|
| |
Gel base q.s. |
|
| 53 |
Mometasone Furoate & Salicylic Acid Ointment |
|
| |
Composition: |
|
| |
Mometasone Furoate IP 0.1% w/w |
|
| |
Salicylic Acid IP 5% w/w |
|
| |
Ointment base q.s. |
|
| 54 |
Mupirocin Ointment IP 2 % w/w |
|
| |
Composition: |
|
| |
Mupirocin IP 2.0 % w/w |
|
| |
In Ointment base q.s. |
|
| 55 |
Nadifloxacin Gel IP 1% w/w |
|
| |
Composition: |
|
| |
Nadifloxacin IP 1.0% w/w |
|
| |
In Gel base q.s. |
|
| 56 |
Ornidazole & Povidone Iodine Ointment |
|
| |
Composition: |
|
| |
Ornidazole IP 1% w/w |
|
| |
Povidone Iodine IP 5% w/w |
|
| |
(Available Iodine 0.5%) |
|
| |
Ointment base q.s. |
|
| 57 |
Povidone Iodine, Metronidazole & Aloevera Ointment |
|
| |
Composition: |
|
| |
Povidone Iodine IP 5.0%w/w |
|
| |
(Available Iodine 0.5%) |
|
| |
Metronidazole IP 1.0%w/w |
|
| |
Aloevera IP 1.5%w/w |
|
| |
Ointment base q.s. |
|
| 58 |
Sucralfate, Metronidazole & Povidone Ointment |
|
| |
Composition: |
|
| |
Sucralfate IP 7.0% w/w |
|
| |
Metronidazole IP 1.0% w/w |
|
| |
Povidione Iodine IP 5.0% w/w |
|
| |
(Available Iodine 0.5%) |
|
| |
Ointment base q.s. |
|
| 59 |
Tacrolimus Ointment 0.03% w/w |
|
| |
Composition: |
|
| |
Tacrolimus USP 0.03% w/w |
|
| |
Ointment base q.s. |
|
| 60 |
Tacrolimus Ointment 0.1% w/w |
|
| |
Composition: |
|
| |
Tacrolimus USP 0.1% w/w |
|
| |
Ointment base q.s. |
|
| 62 |
Urea, lactic Acid, Propylene Glycol & Light Liquid Paraffin Ointment |
|
| |
Composition: |
|
| |
Urea IP 10% w/w |
|
| |
lactic Acid IP 10% w/w |
|
| |
Propylene Glycol IP 10% w/w |
|
| |
Light Liquid Paraffin IP 10% w/w |
|
| |
Ointment base q.s. |
|
| 63 |
Betamethasone Dipropionate & Salicylic Acid Lotion |
|
| |
Composition: |
|
| |
Betamethasone Dipropionate IP 0.064% w/v |
|
| |
Salicylic Acid IP 3% w/v |
|
| |
Lotion base q.s |
|
| 64 |
Calamine, Diphenhydramine Hydrochloride & Camphor Lotion |
|
| |
Composition: |
|
| |
Calamine IP 8.0% w/v |
|
| |
Diphenhydramine Hydrochloride IP 1.0%w/v |
|
| |
Camphor BP 0.1% w/v |
|
| |
Lotion base q.s. |
|
| 65 |
Cetyl Alcohol, Cetostearyl Alcohol and Chlorocresol Lotion |
|
| |
Composition: |
|
| |
Cetyl Alcohol IP 2.65%w/v |
|
| |
Cetostearyl Alcohol IP 0.26%w/v |
|
| |
Cholorocresol IP 0.1% w/v |
|
| |
In a lotion base q.s. |
|
| 66 |
Clobetasol Propionate & Salicylic Acid Lotion |
|
| |
Composition: |
|
| |
Each ml contains: |
|
| |
Clobetasol Propionate IP 0.05% w/v |
|
| |
Salicylic Acid IP 6.0% w/v |
|
| |
In lotion base q.s. |
|
| 67 |
Clobetasol Propionate & Salicylic Acid Lotion |
|
| |
Composition: |
|
| |
Each ml contains: |
|
| |
Clobetasol Propionate IP 0.05% w/v |
|
| |
Salicylic Acid IP 3.0% w/v |
|
| |
In lotion base q.s. |
|
| 68 |
Clobetasol Propionate, Ofloxacin & Miconazole Nitrate Lotion |
|
| |
Composition: |
|
| |
Clobetasol Propionate IP 0.025% w/v |
|
| |
Ofloxacin IP 0.1% w/v |
|
| |
Miconazole Nitrate IP 2.0% w/v |
|
| |
In lotion base q.s. |
|
| 69 |
Clotrimazole & Beclomethasone Lotion |
|
| |
Composition: |
|
| |
Clotrimazole IP 1.00% w/v |
|
| |
Beclomethasone Dipropionate IP 0.025%w/v |
|
| |
In lotion base q.s. |
|
| 70 |
Clotrimazole & Selenium Sulfide Lotion |
|
| |
Composition: |
|
| |
Clotrimazole IP 1% w/v |
|
| |
Selenium Sulfide USP 2.5% |
|
| |
In lotion base q.s. |
|
| 71 |
Coal Tar 1% w/v & Salicylic Acid 3% w/v Topical Solution |
|
| |
Composition: |
|
| |
Coal Tar USP 1% w/v |
|
| |
Salicylic Acid IP 3% w/v |
|
| |
Preservatives |
|
| |
Methylparaben IP 0.2% w/v |
|
| |
Propylparaben IP 0.05% w/v |
|
| 72 |
Desonide Lotion 0.05% w/v |
|
| |
Composition |
|
| |
Desonide 0.05% w/v |
|
| |
Preservatives |
|
| |
Methylparaben IP 0.08% w/v |
|
| |
Propylparaben IP 0.04% w/v |
|
| |
In lotion base q.s. |
|
| 73 |
Halobetasol Propionate & Salicylic Acid lotion |
|
| |
Composition: |
|
| |
Halobetasol Propionate USP 0.05% w/v |
|
| |
Salicylic Acid IP 6% w/v |
|
| |
Preservatives |
|
| |
Methylparaben IP 0.15% w/v |
|
| |
Propylparaben IP 0.15% w/v |
|
| |
In lotion base q.s. |
|
| 74 |
Ketoconazole & Salicylic Acid Lotion |
|
| |
Composition: |
|
| |
Ketoconazole IP 2%w/v |
|
| |
Salicylic Acid IP 2% w/v |
|
| |
Lotion base q.s |
|
| 75 |
Ketoconazole & Zinc Pyrithione Anti-Dandruff Topical Solution |
|
| |
Composition: |
|
| |
Ketoconazole IP 2%w/v |
|
| |
Zinc Pyrithione (ZPTO) 1% w/v |
|
| |
Lotion base q.s |
|
| 76 |
Ketoconazole & Coal Tar Lotion |
|
| |
Composition: |
|
| |
Ketoconazole IP 2.0%w/v |
|
| |
Coal Tar Solution IP 66 2.0%w/v |
|
| |
Aqueous base q.s. |
|
| 77 |
Luliconazole Lotion IP 1% w/v |
|
| |
Composition: |
|
| |
Luliconazole IP 1.0% w/v |
|
| |
Lotion base q.s. |
|
| 78 |
Minoxidil Topical solution USP 5%w/v |
|
| |
Composition: |
|
| |
Minoxidil IP 5%w/v |
|
| |
Base q.s. |
|
| 79 |
Minoxidil Topical solution USP 2%w/v |
|
| |
Composition: |
|
| |
Minoxidil IP 2%w/v |
|
| |
Base q.s. |
|
| 80 |
Minoxidil Topical solution USP 10%w/v |
|
| |
Composition: |
|
| |
Minoxidil IP 10%w/v |
|
| |
Base q.s. |
|
| 81 |
Minoxidil & Finasteride Topical Solution |
|
| |
Composition |
|
| |
Minoxidil IP 5.0%w/v |
|
| |
Finasteride IP 0.1 %w/v |
|
| |
Base q.s. |
|
| 82 |
Mometasone Furoate Lotion 0.1%w/v |
|
| |
Composition |
|
| |
Mometasone Furoate IP 0.1%w/v |
|
| |
Lotion base q.s. |
|
| 83 |
Octinoxate , Avobenzone, Oxybenzone, Octocrylene, Zinc Oxide Sunscreen Lotion |
|
| |
Composition |
|
| |
Octinoxate USP 7.5%w/v |
|
| |
Avobenzone USP 2.0 %w/v, |
|
| |
Oxybenzone USP 3.0%w/v |
|
| |
Octocrylene USP 3.0% w/v |
|
| |
Zinc Oxide IP 2.0 %w/v |
|
| |
Lotion base q.s. |
|
| 84 |
Permethrin & Cetrimide Lotion |
|
| |
Composition |
|
| |
Permethrin BP 5.0% w/v |
|
| |
Cetrimide IP 0.01%w/v |
|
| |
Lotion base q.s. |
|
| 85 |
Permethrin Lotion 5% w/v |
|
| |
Composition |
|
| |
Permethrin BP 5.0% w/v |
|
| |
Lotion base q.s. |
|
| 86 |
Salicylic Acid & Lactic Acid Lotion |
|
| |
Composition |
|
| |
Salicylic Acid IP 16.7%w/v |
|
| |
Lactic Acid IP 16.7%w/v |
|
| |
Lotion base q.s. |
|
| 87 |
Sertaconazole Nitrate Lotion 2% w/v |
|
| |
Composition |
|
| |
Sertaconazole Nitrate IP 2% w/v |
|
| |
Lotion base q.s. |
|
| 88 |
Tacrolimus Lotion 0.1% w/v |
|
| |
Composition: |
|
| |
Tacrolimus IP 0.1% w/v |
|
| |
Lotion base q.s. |
|
| 89 |
White Soft Paraffin & Liquid Paraffin Lotion |
|
| |
Composition: |
|
| |
White Soft Paraffin IP 13.2% w/v |
|
| |
Liquid Paraffin IP 10.2% w/v |
|
| |
Lotion base q.s. |
|
| |
Preservative |
|
| |
Benzyl Alcohol IP 0.5% w/w |
|
| 90 |
Benzydamine Hydrochloride Mouthwash BP 0.15% w/v |
|
| |
Composition |
|
| |
Benzydamine Hydrochloride BP 0.15% w/v |
|
| |
In a flavoured aqueous base q.s. |
|
| |
Approved Colour used |
|
| 91 |
Chlorhexidine Mouthwash IP 0.2% w/v |
|
| |
Composition |
|
| |
Chlorhexidine Gluconate Solution IP |
|
| |
Eq.to Chlorhexidine Gluconate 0.2% w/v |
|
| |
In a flavoured aqueous base q.s. |
|
| |
Approved Colour used |
|
| 92 |
Chlorhexidine Gluconate, Sodium Fluoride & Zinc Chloride Oral Rinse |
|
| |
Composition |
|
| |
Chlorhexidine Gluconate Solution IP |
|
| |
Eq.to Chlorhexidine Gluconate 0.2% w/v |
|
| |
Sodium Fluoride IP 0.05% w/v |
|
| |
Zinc Chloride IP 0.09% w/v |
|
| |
In a Pleasantly flavoured base q.s. |
|
| |
Approved Colour used |
|
| 93 |
Chlorhexidine Gluconate, Metronidazole & Lignocaine Hydrochloride Gel |
|
| |
Composition |
|
| |
Chlorhexidine Gluconate Solution IP |
|
| |
Eq.to Chlorhexidine Gluconate 1.0% w/w |
|
| |
Metronidazole Benzoate IP |
|
| |
Eq. to Metronidazole 1.0% w/w |
|
| |
Lignocaine Hydrochloride IP 2.0% w/w |
|
| |
Gel base q.s. |
|
| 94 |
Choline Salicylate, Benzalkonium Chloride & Lignocaine Hydrochloride Gel |
|
| |
Composition |
|
| |
Choline Salicylate BP 8.7% w/w |
|
| |
Benzalkonium Chloride Solution IP 0.01% w/w |
|
| |
Lignocaine Hydrochloride IP 2.0% w/w |
|
| |
In a flavoured gel base q.s. |
|
| 95 |
Clotrimazole, Beclomethasone Dipropionate, Choline Salicylate, Benzalkonium Chloride Mouth Paint |
|
| |
Composition: |
|
| |
Clotrimazole IP 1.0% w/v |
|
| |
Beclomethasone Dipropionate IP 0.025% w/v |
|
| |
Choline Salicylate Solution BP |
|
| |
Eq. To Choline Salicylate 9.0% w/v |
|
| |
Benzalkonium Chloride |
|
| |
Solution IP 0.02% w/v |
|
| |
Glycerine Base q.s. |
|
| 96 |
Metronidazole & Chlorhexidine Gluconate Mouth Gel |
|
| |
Composition: |
|
| |
Each gram of gel contains: |
|
| |
Metronidazole IP 10mg |
|
| |
Chlorhexidine Gluconate Solution IP |
|
| |
Eq. to Chlorhexidine Gluconate 0.25% w/w |
|
| |
In a Water soluble gel base q.s. |
|
| |
Approved colour used |
|
| 97 |
Sodium Monofluorophosphate Toothpaste |
|
| |
Composition: |
|
| |
Sodium Monofluorophosphate USP 0.35% w/w |
|
| |
In flavoured gel base q.s. |
|
| |
Approved colour used |
|
| 98 |
Sodium Monofluorophosphate, Zinc Sulphate & Alum Toothpaste |
|
| |
Composition: |
|
| |
Sodium Monofluorophosphate USP 0.35% w/w |
|
| |
Zinc Sulphate IP 0.025% w/w |
|
| |
Alum BP 0.025% w/w |
|
| |
In flavoured gel base q.s. |
|
| |
Approved colour used |
|
| 99 |
Potassium Nitrate & Sodium Monofluorophosphate Toothpaste |
|
| |
Composition |
|
| |
Potassium Nitrate BP 5.0% w/w |
|
| |
Sodium Monofluorophosphate USP 0.7% w/w |
|
| |
In a pleasantly flavoured base q.s |
|
| |
Approved colour used |
|
| 100 |
Povidone Iodine Germicide Gargle 2.0% w/v |
|
| |
Composition |
|
| |
Povidone Iodine IP 2.0% w/v |
|
| |
(Available Iodine 0.2% w/v) |
|
| |
Absolute Alcohol Content 8.38% v/v |
|
| |
In mint flavour aqueous base |
|
| 101 |
Chlorhexidine Gluconate Solution + Certimide Antiseptic Solution |
NO |
| |
Composition |
|
| |
Chlorhexidine Gluconate Solution IP 0.3% w/v |
|
| |
Certimide IP 0.6 % w/v |
|
| |
Aqueous base q.s. |
|
| |
Approved colour used |
|
| 102 |
Chlorhexidine Gluconate Solution 2.5% w/v + Isopropyl Alcohol 70 % w/v Hand Antiseptic Solution |
NO |
| |
Composition |
|
| |
Chlorhexidine Gluconate Solution IP 0.3% w/v |
|
| |
(Eq. to 0.5% w/v Chlorhexidine |
|
| |
Gluconate) |
|
| |
Isopropyl Alcohol IP 70 % w/v |
|
| |
Aqueous base q.s. |
|
| |
Approved colour used |
|
| 103 |
Salicylic Acid Foaming Face Wash Solution |
|
| |
Composition |
|
| |
Salicylic Acid IP 1% w/v |
|
| |
Foaming base q.s. |
|